MedTrace Logo

Efficacy of a New Infant Formula Composition on Gut Health in Infants

NCT07242508 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2025-11-21

No results posted yet for this study

Summary

The aim of this study is to investigate potential health benefits of the experimental formula. The main objective is whether the experimental formula elevates the relative abundance of Bifidobacterium in stool samples after 10 weeks, as compared a standard formula, aka control formula. In addition other markers of gut health, such as stool characteristics, and gut health symptoms will be monitored

Conditions

  • Healthy Infants

Interventions

OTHER

Infant Formula

ad-libitum consumption of infant formula

OTHER

Infant Formula with bioactive ingredients

ad-libitum consumption

Sponsors & Collaborators

  • FrieslandCampina

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
0 Days
Max Age
3 Days
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-11-25
Primary Completion
2026-08-19
Completion
2026-08-19

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07242508 on ClinicalTrials.gov